Concentrations of amocarzine in plasma of 71 Ecuadorian patients of two different races receiving 3 mg/kg b.i.d. and 5 mg/kg o.d. oral postprandial doses for 3 days.
The possible influence of sex, race and of postprandial administration conditions (either immediately after the end of meal or one hour later) on the plasma concentrations of amocarzine and its N-oxide metabolite, CGP 13 231, was investigated. 71 Ecuadorian patients (48 males and 23 females) of two different races (Indio and Negro) infected with Onchocerca volvulus participated in the study. The concentrations were measured on day 3 at times 3 and 6 h after postprandial administration in the morning of a treatment with either a dose of 5 mg/kg of amocarzine once daily (12 patients) or 3 mg/kg twice daily (59 patients) for 3 days. The concentrations of unchanged drug and of CGP 13 231 measured after the 5 mg/kg treatment were in the low range of those expected from dose proportionality by the comparison with the 3 mg/kg. After the 3 mg/kg dose, no significant difference in concentration of both compounds were detected between the male and female patients between Indio and Negro patients, between the administration immediately after food intake and one hour later. The only detected difference (P = 0.05) was that between Indio and Negro patients for the concentrations of CGP 13 231 at time 3 h. This difference was not confirmed at time 6 h. Therefore, the administration of amocarzine either immediately or one hour after food intake appeared to produce reproducible absorption conditions which were not influenced by sex and race.
Lecaillon
J B
JB
Biopharmaceutical Research Center, Laboratoires CIBA-GEIGY, Rueil-Malmaison, France.
Godbillon
J
J
Guderian
R
R
Guevara
A
A
Cascante
S
S
Poltera
A A
AA
D000042:Absorption; D000284:Administration, Oral; D044383:Black People; D004334:Drug Administration Schedule; D004484:Ecuador; D005260:Female; D005369:Filaricides / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics*; D005502:Food; D006801:Humans; D007199:Indians, South American; D008297:Male; D009855:Onchocerciasis / Q000188:drug therapy / Q000378:metabolism*; D010879:Piperazines / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics*; D012727:Sex Characteristics
D005369:Filaricides; D010879:Piperazines; C067696:CGP 13231; C051744:amocarzine